跳至主要内容
临床试验/NCT01171014
NCT01171014已完成2 期

A Three-Arm, Placebo Controlled, Double-Blind, Single Center Study to Evaluate the Impact of Probiotic Strain Bifidobacterium Lactis HN019 on Intestinal Well-Being, Colonic Transit Time and Digestive Discomfort

Fonterra Research Centre0 个研究点目标入组 100 人开始时间: 2009年6月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
100
主要终点
Colonic transit time

研究概览

简要总结

The purpose of this study was to investigate the dose response effect of Bifidobacterium lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • healthy males and females aged 25 to 65 years
  • stool type 2-4 on the Bristol Stool Chart
  • 1 to 3 bowel movements per week

排除标准

  • use of any probiotic product intended to improve gastrointestinal function within the 2 weeks preceding study entry
  • major chronic and uncontrolled systemic medical conditions
  • severe gastrointestinal conditions known to prolong CTT
  • lactose intolerance
  • chronic diarrhea
  • gastric bypass surgery or lap band insertion for weight loss
  • regular laxative use
  • pregnant or breast-feeding women

结局指标

主要结局

Colonic transit time

时间窗: 14 days

次要结局

  • Gastrointestinal symptoms(14 days)

研究者

发起方
Fonterra Research Centre
申办方类型
Industry

相似试验